Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 17/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 15/20 | 0.36 |
| ▸ | GSK3B | P49841 | 11/20 | 0.36 |
| ▸ | CDK12 | Q9NYV4 | 3/20 | 0.35 |
| ▸ | CDK13 | Q14004 | 2/20 | 0.35 |
| ▸ | CDK7 | P50613 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31517561 | 0.90 | CCNE1 (0.37) | CDK2CCNE1GSK3B | |
| SCHEMBL31517373 | 0.85 | CDK2 (0.53) | CDK2CCNE1GSK3BCDK12CDK13 | |
| SCHEMBL31517705 | 0.83 | CCNE1 (0.37) | CDK2CCNE1GSK3B | |
| SCHEMBL31588043 | 0.83 | AR (0.35) | CDK2CCNE1GSK3BCDK12CDK13 | |
| SCHEMBL31516892 | 0.83 | CDK2 (0.35) | CDK2CCNE1GSK3BCCNA2CCNA1 | |
| SCHEMBL31516982 | 0.81 | KCNQ2 (0.39) | CDK2CCNE1GSK3BCCNA2CCNA1 | |
| SCHEMBL31516893 | 0.80 | CDK2 (0.37) | CDK2CCNE1GSK3BCCNA2CCNA1 | |
| SCHEMBL31516851 | 0.80 | CCNE1 (0.38) | CDK2CCNE1GSK3B | |
| SCHEMBL31516818 | 0.79 | P2RX7 (0.40) | CDK2CCNE1GSK3BCCNA2CCNA1 | |
| SCHEMBL31516946 | 0.79 | CDK2 (0.37) | CDK2CCNE1GSK3BCCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025040546-A1 | PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS | PROXYGEN GMBH (AT) | 2025-02-27 | — | — | WO | disclosed |